NK phenotype and/or cytotoxic-cell cutaneous lymphomas;Lymphomes cutanés à cellules de phénotype NK et/ou cytotoxique

Annales de Dermatologie et de Venereologie

Volumn 131, Issue 8-9, 2004, Pages 837-841

  Dereure, O ^a  

^a HÔPITAL SAINT ELOI   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEDIATED CYTOTOXICITY; CLINICAL FEATURE; DISEASE COURSE; HUMAN; MAJOR HISTOCOMPATIBILITY COMPLEX; MYCOSIS FUNGOIDES; NATURAL KILLER CELL; PHENOTYPE; REVIEW; SKIN LYMPHOMA;

EID: 4744365528     PISSN: 01519638     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0151-9638(04)93775-1     Document Type: Review

References (24)

1. Radonich MA, Lazova R, Bolognia J. Cutaneous natural killer/T cell lymphoma. J Am Acad Dermatol 2002;46:451-6.
2. Santucci M, Pimpinelli N, Massi D, Kadin ME Meijer CJLM, Müller-Hermelink HK et al. Cytotoxic/Natural Killer cell cutaneous lymphomas. Report of the EORTC Cutaneous Lymphoma Task Force Workshop. Cancer 2003:97:610-27.
3. Russel-Jones R. World Health Organization classification of hematopoietic and lymphoid tissues: implications for dermatology. J Am Acad Dermatol 2003;48:93-102.
4. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S et al. EORTC classification for primary cutaneous lymphomas: a proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 1997;90:354-71.
5. Berti E, Tomasini D, Vermeer MH, Meijer CJ, Alessi E, Willemze R. Primary cutaneous CD8-positive epidermotropic cytotoxic T cell lymphomas. A distinct clinicopathological entity with an aggressive clinical behavior. Am J Pathol 1999;155:483-92.
6. Petrella T, Dalac S, Maynadie M, Mugneret F, Thomine E, Courville P et al. CD4+ CD56+ cutaneous neoplasms: a distinct hematological entity? Groupe Francais d'Etude des Lymphomes Cutanés (CFELC). Am J Surg Pathol 1999;23:137-46.
7. Petrella T, Comeau MR, Maynadie M, Couillault C, De Muret A, Maliszewski CR, et al. 'Agranular CD4+ CD56+ hematodermic neoplasm' (blastic NK-cell lymphoma) originates from a population of CD56+ precursor cells related to plasmacytoid monocytes. Am J Surg Pathol 2002;26:852-62.
8. Touahri T, Belaouni H, Mossafa H, Pulik M, Bourguigna L, Iborra C, et al. Agranular CD4+/ CD56+ cutaneous neoplasm. Leuk Lymphoma 2002;43:1475-9.
9. Child FJ, Mitchell TJ, Whittaker SJ, Calonje E, Spittle M, Cracker J, et al. Blastic natural killer cell and extranodal natural killer cell-like T-cell lymphoma presenting in the skin: report of six cases from the UK. Br J Dermatol 2003;148:507-15.
10. Penven K, Macro M, Salaun V, Comoz F, Reman O, Leroy D, et al. Skin manifestations in CD4+, CD56+ malignancies. Eur J Dermatol 2003;13:161-5.
11. Gonzalez CL, Medeiros LJ, Braziel RM, Jaffe ES. T-cell lymphoma involving subcutaneous tissue. A clinicopathologic entity commonly associated with hemophagocytic syndrome. Am J Surg Pathol 1991;15:17-27.
12. Salhany KE, Macon WR, Choi JK, Elenitsas R, Lessin SR, Felgar RE et al. Subcutaneous panniculitis-like T-cell lymphoma: clinicopathologic, immunophenotypic, and genotypic analysis of alpha/beta and gamma/delta subtypes. Am J Surg Pathol 1998;22:881-93.
13. Kumar S, Krenacs L, Medeiros J, Elenitoba-Johnson KS, Greiner TC, Sorbara L, et al. Subcutaneous panniculitis T-cell lymphoma is a tumor of cytotoxic lymphocytes. Hum Pathol 1998;29:397-403.
14. Marzano AV, Berti E, Paulli M, Caputo R. Cytophagic histiocytic panniculitis and subcutaneous panniculitis-like T-cell lymphoma: report of 7 cases. Arch Dermatol 2000;136:889-96.
15. Hoque SR, Child FJ, Whittaker SJ, Ferreira S, Orchard C, Jenner K, et al. Subcutaneous panniculitis-like T-cell lymphoma: a clinicopathological, immunophenotypic and molecular analysis of six patients. Br J Dermatol 2003;148:516-25.
16. Miyamoto T, Yoshino T, Takehisa T, Hagari Y, Mihara M. Cutaneous presentation of nasal/nasal type T/NK cell lymphoma: clinicopathological findings of four cases. Br J Dermatol 1998;139:481-7.
17. Hirakawa S, Kuyama M, Takahashi S, Yamasaki O, Kanzaki H, Teshima T, et al. Nasal and nasal-type natural killer/T-cell lymphoma. J Am Acad Dermatol 1999;40:268-72.
18. Kato N, Yasukawa K, Onozuka T, Kikuta H. Nasal and nasal-type T/NK-cell lymphoma with cutaneous involvement. J Am Acad Dermatol 1999;40:850-6.
19. Jang KA, Choi JH, Sung KJ, Moon KC, Koh JK, Kwon YM, et al. Primary CD56 + nasal-type T/natural killer-cell subcutaneous panniculitic lymphoma: presentation as haemophagocytic syndrome. Br J Dermatol 1999;141:706-9.
20. Takeshita M, Yamamoto M, Kikuchi M, Kimura N, Nakayama J, Dike N, et al. Angiodestruction and tissue necrosis of skin-involving CD56+ NK/T-cell lymphoma are influenced by expression of cell adhesion molecules and cytotoxic granule and apoptosis-related proteins. Am J Clin Pathol 2000;113:201-11.
21. Mraz-Cernhard S, Natkunam Y, Hoppe RT, LeBoit P, Kohler S, Kim YH. Natural killer/natural killer-like T-cell lymphoma, CD56+, presenting in the skin: an increasingly recognized entity with an aggressive course. J Clin Oncol 2001;19:2179-88.
22. Shen L, Liang ACT, Lu L, Au WY, Kwong YL, Liang RHS, et al. Frequent deletion of Fas gene sequences encoding death and transmembrane domains in nasal natural killer/T-cell lymphoma. Am J Pathol 2002;161:2123-31.
23. Cheung MM, Chan JK, Wong KF. Natural killer cell neoplasms: a distinctive group of highly aggressive lymphomas/leukemias. Semin Hematol 2003;40:221-32.
24. Ginarte M, Abalde MT, Peteiro C, Fraga M, Alonso N, Toribio J. Blastoid NK cell leukemia/lymphoma with cutaneous involvement. Dermatology 2000;201:268-71.